The interplay of drug therapeutics and immune responses to SARS-CoV-2

被引：5
|
作者：
Fumagalli, Valeria [1 ,2 ]
Iannacone, Matteo [1 ,2 ,3 ]
机构：
[1] IRCCS San Raffaele Sci Inst, Div Immunol Transplantat & Infect Dis, Milan, Italy
[2] Univ Vita Salute San Raffaele, Milan, Italy
[3] IRCCS San Raffaele Sci Inst, Expt Imaging Ctr, Milan, Italy
来源：
CELLULAR & MOLECULAR IMMUNOLOGY | 2024年 / 21卷 / 02期
基金：
欧洲研究理事会;
关键词：
SARS-CoV-2; Nirmatrelvir; Bisphosphonates; Adaptive immunity; Drug repurposing; ZOLEDRONIC ACID; BISPHOSPHONATE THERAPY; CELLS; MECHANISMS; MONOCYTES; SAFETY;
D O I：
10.1038/s41423-023-01098-7
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
The SARS-CoV-2 pandemic has necessitated rapid therapeutic and preventative responses. While vaccines form the frontline of defense, antiviral treatments such as nirmatrelvir have emerged as vital adjunctive measures, particularly for those unable or unwilling to be vaccinated. This review delves into the potential influence of nirmatrelvir on enduring immunity. In parallel, the potential of drug repurposing is explored, with bisphosphonates being examined for their possible effects against COVID-19 due to their immunomodulatory properties. The importance of rigorous clinical trials and careful interpretation of preliminary data is emphasized.
引用
收藏
页码：197 / 200
页数：4
相关论文
共 50 条
  • [41] Understanding SARS-CoV-2 endocytosis for COVID-19 drug repurposing
    Glebov, Oleg O.
    FEBS JOURNAL, 2020, 287 (17) : 3664 - 3671
  • [42] Repurposing Quinoline and Artemisinin Antimalarials as Therapeutics for SARS-CoV-2: Rationale and Implications
    Firestone, Tessa M.
    Oyewole, Opeoluwa O.
    Reid, St Patrick
    Ng, Caroline L.
    ACS PHARMACOLOGY & TRANSLATIONAL SCIENCE, 2021, 4 (02) : 613 - 623
  • [43] SARS-CoV-2 Induces Cytokine Responses in Human Basophils
    Bonam, Srinivasa Reddy
    Chauvin, Camille
    Levillayer, Laurine
    Mathew, Mano Joseph
    Sakuntabhai, Anavaj
    Bayry, Jagadeesh
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [44] Escape and Over-Activation of Innate Immune Responses by SARS-CoV-2: Two Faces of a Coin
    Mattoo, Sameer-ul-Salam
    Kim, Seong-Jun
    Ahn, Dae-Gyun
    Myoung, Jinjong
    VIRUSES-BASEL, 2022, 14 (03):
  • [45] An epithelial-immune circuit amplifies inflammasome and IL-6 responses to SARS-CoV-2
    Barnett, Katherine C.
    Xie, Yuying
    Asakura, Takanori
    Song, Dingka
    Liang, Kaixin
    Taft-Benz, Sharon A.
    Guo, Haitao
    Yang, Shuangshuang
    Okuda, Kenichi
    Gilmore, Rodney C.
    Loome, Jennifer F.
    Oguin III, Thomas H.
    Sempowski, Gregory D.
    Randell, Scott H.
    Heise, Mark T.
    Lei, Yu Leo
    Boucher, Richard C.
    Ting, Jenny P. -Y.
    CELL HOST & MICROBE, 2023, 31 (02) : 243 - +
  • [46] SARS-CoV-2 and extracellular vesicles: An intricate interplay in pathogenesis, diagnosis and treatment
    Sbarigia, C.
    Vardanyan, D.
    Buccini, L.
    Tacconi, S.
    Dini, L.
    FRONTIERS IN NANOTECHNOLOGY, 2022, 4
  • [47] Different Innate and Adaptive Immune Responses to SARS-CoV-2 Infection of Asymptomatic, Mild, and Severe Cases
    Carsetti, Rita
    Zaffina, Salvatore
    Mortari, Eva Piano
    Terreri, Sara
    Corrente, Francesco
    Capponi, Claudia
    Palomba, Patrizia
    Mirabella, Mattia
    Cascioli, Simona
    Palange, Paolo
    Cuccaro, Ilaria
    Milito, Cinzia
    Zumla, Alimuddin
    Maeurer, Markus
    Camisa, Vincenzo
    Vinci, Maria Rosaria
    Santoro, Annapaola
    Cimini, Eleonora
    Marchioni, Luisa
    Nicastri, Emanuele
    Palmieri, Fabrizio
    Agrati, Chiara
    Ippolito, Giuseppe
    Porzio, Ottavia
    Concato, Carlo
    Muda, Andrea Onetti
    Raponi, Massimiliano
    Quintarelli, Concetta
    Quinti, Isabella
    Locatelli, Franco
    FRONTIERS IN IMMUNOLOGY, 2020, 11
  • [48] A Structural Comparison of Oral SARS-CoV-2 Drug Candidate Ibuzatrelvir Complexed with the Main Protease (Mpro) of SARS-CoV-2 and MERS-CoV
    Chen, Pu
    Van Oers, Tayla J.
    Arutyunova, Elena
    Fischer, Conrad
    Wang, Chaoxiang
    Lamer, Tess
    van Belkum, Marco J.
    Young, Howard S.
    Vederas, John C.
    Lemieux, M. Joanne
    JACS AU, 2024, 4 (08): : 3217 - 3227
  • [49] Autoimmune response after SARS-CoV-2 infection and SARS-CoV-2 vaccines
    Hromic-Jahjefendic, Altijana
    Lundstrom, Kenneth
    Adilovic, Muhamed
    Aljabali, Alaa A. A.
    Tambuwala, Murtaza M.
    Serrano-Aroca, Angel
    Uversky, Vladimir N.
    AUTOIMMUNITY REVIEWS, 2024, 23 (03)
  • [50] Reviewing immunopathology characteristics of SARS-CoV-2 for cancer entwisted with SARS-CoV-2
    Li, Hongyan
    Lu, Wanting
    Li, Yinyin
    Lu, Yinying
    Li, Fei
    SAGE OPEN MEDICINE, 2021, 9
12345